INTS vs NSC
Intensity Therapeutics, Inc. Common stock (INTS) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported NSC revenue for 2024-12-31 was $12.12B. Net income was $2.62B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
INTS currently screens at market cap $7.7M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the INTS and NSC stock pages for the full models.
Not investment advice.